Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 115
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Infection ; 47(2): 301-305, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30128751

RESUMEN

Musculoskeletal hydatidosis is a rare but severe disease in central Europe. This case report presents the incidental finding of an osseous hydatidosis after cementless revision total hip arthroplasty in a patient without a preoperative history of hydatidosis or any clinical symptoms. Revision total hip arthroplasty had been necessary due to a septic osteonecrosis of the femoral head 2 years after osteosynthesis of a traumatic proximal femur fracture with a sliding hip screw. The positive sample was taken out of the greater trochanter in the area of the possible former entry point for the lag screw, which was macroscopic inconspicuous. Sero-analysis could afterwards confirm the suspected diagnosis. Postoperative chemotherapy with albendazole was performed for 6 months. A full-body MRI did not reveal any further cysts. This case demonstrates a possible impact of migration on the expected pathogens in revision arthroplasty. This demonstrates that in revision arthroplasty, an infection with this parasite also has to be taken into account, if the patients come from an area endemic for hydatidosis.


Asunto(s)
Albendazol/uso terapéutico , Anticestodos/uso terapéutico , Artroplastia de Reemplazo de Cadera , Enfermedades Óseas/diagnóstico , Equinococosis/diagnóstico , Reoperación , Adolescente , Argelia , Enfermedades Óseas/parasitología , Enfermedades Óseas/cirugía , Equinococosis/parasitología , Equinococosis/cirugía , Fémur/lesiones , Fémur/parasitología , Alemania , Humanos , Masculino , Resultado del Tratamiento
2.
Pathologe ; 40(1): 101-118, 2019 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-30706100

RESUMEN

High resolution cross-sectional imaging techniques means that even small, well-differentiated hepatocellular tumors can also be diagnosed with biopsy. In cirrhotic liver tissue, macroregenerative and dysplastic nodules must be discriminated from hepatocellular cancer (HCC). In non-cirrhotic liver tissue the differential diagnosis includes hepatocellular adenoma, macroregeneratory nodules, fibrolamellar carcinoma, as well as primary tumors and metastases. The diagnostic procedure includes matrix diagnosis of the tumor-bearing liver tissue, cyto- and histomorphologic analysis including capillarization of vascular bed, and adapted immunohistological testing with antibodies which underline possible malignancy or hepatocellular differentiation. A flow chart for the diagnosis of hepatocellular carcinomas and their mimics on liver biopsies is presented.


Asunto(s)
Adenoma de Células Hepáticas , Carcinoma Hepatocelular , Cirrosis Hepática , Neoplasias Hepáticas , Diagnóstico Diferencial , Humanos
3.
Pathologe ; 36(6): 597-606; quiz 607-8, 2015 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-26496997

RESUMEN

In recent years, the spectrum of tissue-based diagnostics of hepatocellular tumours has changed due to novel molecular pathological findings. Innovative radiographics filter out small lesions and ambiguous tumours for bioptical sampling. The spectrum of these tumours includes hepatocellular carcinoma, hepatocellular adenomas, focal nodular hyperplasia and macroregenerative nodules. Primarily, morphological analysis should identify the dignity of a lesion. After exclusion of HCC and reactive liver cell nodules, hepatocellular adenomas should be further subclassified based on immunohistochemical/molecular pathological criteria according to the WHO classification of liver tumours. This procedure provides significant additional information regarding the prognosis and therapeutic implications of hepatocellular adenomas.


Asunto(s)
Carcinoma Hepatocelular/patología , Cirrosis Hepática/patología , Neoplasias Hepáticas/patología , Hígado/patología , Adenoma de Células Hepáticas/patología , Adolescente , Adulto , Anciano , Biomarcadores de Tumor/análisis , Biopsia , Transformación Celular Neoplásica/patología , Diagnóstico Diferencial , Femenino , Hiperplasia Nodular Focal/patología , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Patología Molecular/métodos , Factores de Riesgo , Adulto Joven
4.
Z Gastroenterol ; 51(9): 1096-100, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24022205

RESUMEN

PURPOSE: Perivascular epitheloid cell tumour [PEComa] is a rare neoplasm entity, characterized by perivascular epitheloid cells with a coexpression of smooth muscle and melanocytic markers. PEComas are found in a variety of localizations, though lesions within the liver are still scarcely found. Although the majority of these tumours are recognized as benign, there are some reports about advanced and aggressive tumours even with fatal outcome. By means of this case report and literary review including other 21 published cases, potential treatment modalities concerning clinical diagnostics, therapy and the follow-up care should be discussed. METHODS: The following report presents the case of a 53-year old woman with a known liver lesion, since four years under regularly sonographic controls. Finally, after a haemorrhage episode, the lesion was resected and the diagnosis found. For the literary review a systematic search for case reports published between January 1, 1999 and May 1, 2012 was performed on Pubmed. RESULTS: The only way, till now, of confirming the diagnosis is through immunohistochemical examinations. The already published Malignancy criteria by Folpe et al. must be taken carefully in question, as there are cases of malignant behaviour, that do not exactly coincide with these. CONCLUSION: Primary PEComa of the liver must be treated as potential malignant and therefore a close follow-up is demanded.


Asunto(s)
Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/cirugía , Neoplasias de Células Epitelioides Perivasculares/diagnóstico , Neoplasias de Células Epitelioides Perivasculares/cirugía , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Neoplasias de Células Epitelioides Perivasculares/clasificación , Resultado del Tratamiento
5.
Pathologe ; 34(4): 318-22, 2013 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-23392740

RESUMEN

BACKGROUND: In rare cases, hypothalamic-pituitary dysfunction can be associated with an extraordinarily active non-alcoholic steatohepatitis (NASH) and subsequent liver cirrhosis. CASE REPORT: The two young adult patients described in this report presented with NASH together with advanced liver fibrosis and cirrhosis 5 and 19 years, respectively after resection of a craniopharyngeoma. CONCLUSIONS: In young patients and children with active steatohepatitis, an association with hypothalamic-pituitary dysfunction should be excluded. Especially hypothalamic-pituitary-related NASH tends to develop rapidly into liver cirrhosis.


Asunto(s)
Hígado Graso/patología , Adolescente , Biopsia , Niño , Preescolar , Craneofaringioma/cirugía , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/patología , Diabetes Mellitus Tipo 2/fisiopatología , Diagnóstico Diferencial , Hígado Graso/diagnóstico , Hígado Graso/fisiopatología , Femenino , Estudios de Seguimiento , Humanos , Sistema Hipotálamo-Hipofisario/fisiopatología , Hígado/patología , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/patología , Cirrosis Hepática/fisiopatología , Imagen por Resonancia Magnética , Enfermedad del Hígado Graso no Alcohólico , Neoplasias Hipofisarias/cirugía , Sistema Hipófiso-Suprarrenal/fisiopatología , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/patología , Complicaciones Posoperatorias/fisiopatología , Adulto Joven
6.
Z Gastroenterol ; 48(10): 1211-4, 2010 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-20886426

RESUMEN

Here we report on a patient with a primary hepatocellular carcinoma in a non-cirrhotic liver, in whom heterozygosity for an AAT-deficiency allele was found (PiMZ). Based on this observation and the current literature, the possible mechanisms for an eventual contribution of a heterozygosity of a heterozygous AAT-deficiency for a hepatocellular carcinoma are discussed. Alpha-1-antitrypsin (AAT)-deficiency (Laurell-Eriksson syndrome) is a genetic disorder, in which individuals who are homozygous for a deficiency allele are at an increased lifetime risk for pulmonary emphysema, liver cirrhosis, and primary hepatocellular carcinoma. It has been controversially discussed whether the heterozygous form (PiMZ) is also associated with an increased risk for liver diseases. Hepatocarcinogenesis for AAT-deficiency is probably based on a series of toxic events. Precipitation of AAT aggregates in hepatocytes is the initial step. These accumulate in the endoplasmic reticulum and cannot be eliminated from all hepatocytes by proteasomal and non-proteasomal mechanisms. AAT aggregates induce proinflammatory pathways and may be a stimulus for hepatocarcinogenesis. This hypothesis is based mostly on studies of individuals homozygous for a deficiency allele (PiZZ). The mechanism may also play a role in heterozygous patients. Since not all patients with precipitates of AAT-aggregates are develop a hepatocellular carcinoma related comorbidities such as chronic hepatitis B, C, chronic alcohol abuse, or so far unknown genetic and environmental factors may be crucial.


Asunto(s)
Carcinoma Hepatocelular/genética , Predisposición Genética a la Enfermedad/genética , Neoplasias Hepáticas/genética , Pérdida de Heterocigocidad/genética , Polimorfismo de Nucleótido Simple/genética , alfa 1-Antitripsina/genética , Anciano , Carcinoma Hepatocelular/metabolismo , Humanos , Cirrosis Hepática/genética , Neoplasias Hepáticas/metabolismo , Masculino , Medición de Riesgo , Factores de Riesgo
7.
HNO ; 58(9): 931-3, 2010 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-20464358

RESUMEN

Urbach-Wiethe syndrome (hyalinosis cutis et mucosae) is an autosomal-recessive inherited disease. It often presents with typical symptoms such as skin lesions (especially in the face and neck area), dyspnea, and maldigestion. Hoarseness is a leading symptom in young children. These manifestations are caused by the assimilation of glycoproteins in mesenchymal tissue. Our case report shows that hoarseness does not necessarily appear only in children, but can also appear later. Furthermore, the assimilation of glycoproteins in the supraglottic area may also cause dysphonia. Due to the varied features of this disease, interdisciplinary check-ups are necessary at regular intervals.


Asunto(s)
Disfonía/diagnóstico , Epiglotis/patología , Neoplasias Laríngeas/diagnóstico , Proteinosis Lipoidea de Urbach y Wiethe/complicaciones , Proteinosis Lipoidea de Urbach y Wiethe/diagnóstico , Neumonía/diagnóstico , Humanos , Presión , Recurrencia
8.
Science ; 217(4559): 505-10, 1982 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-17820519

RESUMEN

The science of chemistry and chemicals will continue to be an integral part of future crop production technologies. In assessing and defining the future role of chemistry three imperatives must be considered: (i) the necessity to preserve natural resources, (ii) the complementary solutions offered by the rapidly advancing biological sciences, and (iii) the specific requirements of developing regions where increasing crop productivity is most important. Chemical research objectives for improving crop protection and crop growth must take into account the perceivable and potential changes in crop production techniques, which, in turn, are dictated by a number of accentuating constraints.

9.
BMC Cancer ; 8: 290, 2008 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-18840281

RESUMEN

BACKGROUND: Whereas the antimicrobial peptides hBD-2 and -3 are related to inflammation, the constitutively expressed hBD-1 might function as 8p tumour suppressor gene and thus play a key role in control of transcription and induction of apoptosis in malignant epithelial tumours. Therefore this study was conducted to characterise proteins involved in cell cycle control and host defence in different benign and malignant salivary gland tumours in comparison with healthy salivary gland tissue. METHODS: 21 paraffin-embedded tissue samples of benign (n = 7), and malignant (n = 7) salivary gland tumours as well as healthy (n = 7) salivary glands were examined immunohistochemically for the expression of p53, bcl-2, and hBD-1, -2, -3. RESULTS: HBD-1 was distributed in the cytoplasm of healthy salivary glands and benign salivary gland tumours but seems to migrate into the nucleus of malignant salivary gland tumours. Pleomorphic adenomas showed cytoplasmic as well as weak nuclear hBD-1 staining. CONCLUSION: HBD-1, 2 and 3 are traceable in healthy salivary gland tissue as well as in benign and malignant salivary gland tumours. As hBD-1 is shifted from the cytoplasm to the nucleus in malignant salivary gland tumours, we hypothesize that it might play a role in the oncogenesis of these tumours. In pleomorphic adenomas hBD-1 might be connected to their biologic behaviour of recurrence and malignant transformation.


Asunto(s)
Núcleo Celular/metabolismo , Neoplasias de las Glándulas Salivales/metabolismo , beta-Defensinas/metabolismo , Adenoma Pleomórfico/metabolismo , Carcinoma Adenoide Quístico/metabolismo , Estudios de Casos y Controles , Citoplasma/metabolismo , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Glándulas Salivales/metabolismo , Glándulas Salivales/patología , Proteína p53 Supresora de Tumor/metabolismo
10.
Eur J Med Res ; 13(10): 483-6, 2008 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-19008178

RESUMEN

BACKGROUND: Reactivation of chronic hepatitis B in HBsAg carriers is a well known complication of chemo?therapy. The clinical spectrum ranges from asymptomatic hepatitis to fatal hepatic failure. Although it impairs the prognosis of cancer treatment, it may be overlooked due to other possible causes of liver damage. CASE REPORT: The patient presented with acute liver failure after 6 cycles of rituximab, fludarabine, and cyclophosphamide for low grade non-hodgkin's lymphoma. Differential diagnoses were chemotherapy-induced liver failure, autoimmune hepatitis, phenprocoumon-induced liver failure and infiltration of the liver by lymphoma. Finally, reactivation of hepatitis B with a fibrosing cholestatic pattern was identified. CONCLUSION: This case reminds clinicians that patients receiving high-intensive chemotherapy or immunosuppressive therapy should be screened for HBsAg. HbsAg positive patients should obtain prophylactic antiviral therapy with lamivudine or another substance active against HBV.


Asunto(s)
Anticuerpos Monoclonales/efectos adversos , Ciclofosfamida/efectos adversos , Hepatitis B Crónica/complicaciones , Fallo Hepático Agudo/etiología , Linfoma no Hodgkin/tratamiento farmacológico , Vidarabina/análogos & derivados , Anticuerpos Monoclonales de Origen Murino , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Diagnóstico Diferencial , Resultado Fatal , Hepatitis B Crónica/diagnóstico , Hepatitis B Crónica/patología , Humanos , Hígado/patología , Fallo Hepático Agudo/patología , Masculino , Persona de Mediana Edad , Recurrencia , Rituximab , Vidarabina/efectos adversos
11.
Pathologe ; 29(1): 6-14, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18210109

RESUMEN

Liver biopsy plays an important role in the diagnosis of liver diseases. Nowadays, biochemical, immunological, functional and molecular tests allow the etiology of many liver diseases to be clarified. The liver biopsy contributes essential information about the stage and grade of inflammatory liver diseases on the basis of consensus criteria. These data influence treatment and help to assess the prognosis. In addition, the different patterns of fibrosis allow conclusions about the cause and progress of the underlying liver disease. Hepatitis C, autoimmune hepatitis, unexplained severe course of hepatitis B, differentiation of simple steatosis from steatohepatitis, the differential diagnosis of cholestatic diseases, unclear hepatopathy, transplant pathology and last but not least, hepatic masses are the focal points of liver biopsy diagnoses. Increased risk of hemorrhage due to coagulation defects can be minimized by a transjugular biopsy. Liver masses can be effectively located and identified by radiologically or ultrasound-guided biopsy. Regular periodic conferences between clinicians and pathologists help to clarify individual problematic cases and will promote the diagnostic competence of both partners in hepatology.


Asunto(s)
Biopsia/métodos , Hepatopatías/patología , Hígado/patología , Biopsia/efectos adversos , Hígado Graso/patología , Femenino , Hemorragia/etiología , Hemorragia/patología , Hepatitis/complicaciones , Hepatitis/patología , Hepatitis B/complicaciones , Hepatitis B/patología , Hepatitis C/complicaciones , Hepatitis C/patología , Humanos , Cirrosis Hepática Alcohólica/patología , Masculino , Variaciones Dependientes del Observador , Pronóstico , Reproducibilidad de los Resultados
12.
Pathologe ; 29(1): 37-46, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18210108

RESUMEN

Sinusoidal alterations unrelated to primary hepatocellular damage present without characteristic clinical findings and in these cases the liver biopsy is particularly important. Capillarization of sinusoids is characterized by closing of fenestration, formation of a basal membrane and by the expression of CD34 and is typical for active cirrhosis. In nodular regeneratory hyperplasia, capillarization indicates a local or general disturbance of perfusion. In large regenerative nodules, focal nodular hyperplasia and liver cell adenoma CD34-positive capillaries reflect afferent parts and CD34-negative sinusoids the efferent parts of the parenchymal vascular bed. HCC generally have a completely capillarized CD34-positive vascular bed. Hepatic angiosarcomas and epithelioid hemangioendotheliomas can be easily overseen in liver biopsies, if they spread along the sinusoids without detoriation of the acinar architecture and without significant alteration of the surrounding liver cell plates. Toxic damage of endothelial cells, post-sinusoidal stasis and sinusoidal hyperperfusion are the underlying pathogenetic principles of sinusoidal injury. Rupture and loss of the perisinusoidal reticulin fibres lead to peliosis hepatis. In these cases liver biopsy might disclose occlusion of the terminal liver veins (VOD). Perisinusoidal fibrosis can be caused by intrasinusoidal accumulation of pathologic cells, advanced intrasinusoidal macrophagocytic storage diseases and by activation of the vitamin A-storing hepatic stellate cells. Perisinusoidal amyloidosis can be the first sign of an underlying B-cell neoplasia.


Asunto(s)
Biopsia/métodos , Células Endoteliales/patología , Enfermedad Veno-Oclusiva Hepática/patología , Neoplasias Hepáticas/patología , Hígado/patología , Antígenos CD/análisis , Antígenos CD34/análisis , Venas Hepáticas/patología , Humanos , Circulación Hepática , Cirrosis Hepática/patología , Vasodilatación
13.
Pathologe ; 29(1): 73-83, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18210110

RESUMEN

Primary hemochromatosis, alpha-1-antitrypsin (AAT) deficiency, and Wilson's disease are the most common hereditary causes of unclear hepatopathy. Classical primary hemochromatosis (type I) on the basis of a homozygous mutation of the HFE gene, usually presents in adults with increasing hepatocellular siderosis and chronic progressive necroinflammatory liver disease. Homozygous AAT deficiency type PiZZ becomes manifest in newborns as a giant cell hepatitis or findings similar to bile duct atresia, in adults as chronic hepatitis or "cryptogenic cirrhosis". The heterozygous PiZ mutation can lead to PAS-positive hepatocellular AAT deposits increasing over the life time. Immunohistochemical detection of AAT deposits by specific PiZ antibodies is a highly sensitive and specific supplementary method. Molecular analysis of AAT and HFE genes in paraffin-embedded tissue or blood can confirm the diagnosis and allows the zygosity status to be defined. Wilson's disease has to be considered in children and young adults with unexplained histologic findings of chronic hepatitis or steatohepatitis. Rhodanin staining is the most effective histochemical method to detect free copper deposits, but negative staining results do not exclude Wilson's disease. In cases suspected of Wilson's disease further clinical exploration must be initiated. The diagnosis is based on a combination of clinical and biochemical findings, which can be supplemented by mutation analysis of the ATP7B gene.


Asunto(s)
Hemocromatosis/genética , Hemocromatosis/patología , Degeneración Hepatolenticular/patología , Deficiencia de alfa 1-Antitripsina/patología , Adenosina Trifosfatasas/genética , Adulto , Proteínas de Transporte de Catión/genética , Niño , Cobre/análisis , ATPasas Transportadoras de Cobre , Diagnóstico Diferencial , Tamización de Portadores Genéticos , Hepatitis/genética , Hepatitis/patología , Humanos , Hepatopatías/genética , Hepatopatías/patología , Mutación , Pronóstico , Adulto Joven
14.
Pathologe ; 29(1): 27-36, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18210115

RESUMEN

Pathological findings in the liver sinusoids are mostly caused by extrahepatic or systemic diseases. Unclear fever, hepatosplenomegaly, portal hypertension or a mild elevation of liver enzymes are reasons for a liver biopsy leading to path-breaking diagnoses. Reactive intrasinusoidal lymphocytosis, especially with Epstein-Barr virus infections, has to be differentiated from predominantly intrasinusoidal lymphoproliferative malignancies. Intrasinusoidal megakaryocytes can be the first sign of a myeloproliferative or myelodestructive disease. Intrasinusoidal carcinosis and melanomatosis might present radiologically without tumor lesions and are easily overlooked histologically, in particular, if the critical cells have a similar size to hepatocytes. This also applies for intrasinusoidal storing macrophages. Gaucher's disease type I, and some other subtypes of inborn storage diseases might present for the first time in adulthood by hepatomegaly and Kupffer cell hypertrophy. Accompanying perisinusoidal fibrosis and immunohistochemical staining (CD68) can help to detect the large pale intrasinusoidal macrophages. In immunocompromized patients with fever, particular attention must be paid to intracellular agents, especially atypical mycobacteria and yeasts in non-granulomatous nested or dispersed Kupffer cells. Leishmaniasis with amastigotes in macrophages is accompanied by reactive sinusoidal plasmocytosis.


Asunto(s)
Biopsia/métodos , Cirrosis Hepática/patología , Hígado/patología , Antígenos CD/análisis , Antígenos de Diferenciación Mielomonocítica/análisis , Infecciones por Virus de Epstein-Barr/patología , Fiebre/patología , Conducto Hepático Común/patología , Hepatomegalia/patología , Humanos , Inmunohistoquímica , Macrófagos del Hígado/patología , Linfoma/patología , Esplenomegalia/patología
15.
Pathologe ; 29(1): 61-72, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18210117

RESUMEN

Cholestasis in neonates and infants frequently confronts pediatricians and pathologists with diagnostic problems. A specific feature of the liver in neonates is the ability to react to different causative factors with a non-specific hepatitis-like picture, the so-called neonatal hepatitis. A diagnostic discrimination of the various diseases is histologically only possible with close attention to typical morphologic features. Thus, extrahepatic biliary obstructions, such as atresia or stenosis of the hepatic duct or choledochal cysts present with portal bile duct proliferation and signs of bile retention in the neoducts. In Alagille syndrome (arteriohepatic dysplasia), however, paucity of intrahepatic bile ducts is an important diagnostic feature. Metabolic disorders, such as fructosemia and galactosemia are additionally associated with steatosis. Knowledge of the clinical course and laboratory and imaging data are necessary to make the definitive diagnosis in synopsis with the morphologic findings and requires a close co-operation between the pediatrician and the pathologist.


Asunto(s)
Carcinoma Hepatocelular/patología , Carcinoma Neuroendocrino/patología , Colestasis/complicaciones , Neoplasias Hepáticas/patología , Adulto , Carcinoma Hepatocelular/cirugía , Carcinoma Neuroendocrino/cirugía , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Neoplasias Hepáticas/cirugía
16.
Pathologe ; 29(1): 53-60, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18210116

RESUMEN

Primary hepatic neuroendocrine tumors are rare neoplasms. While primary hepatic carcinoid tumors (PHCT) are well-differentiated tumors, primary hepatic small-cell carcinomas (PHSCC) represent the poorly differentiated end of the spectrum of neuroendocrine carcinomas. The first patient, suffering from PHCT, has had a follow-up for 32 years and is still alive. Within this time, the tumor relapsed 4 times with unchanged histology and immunohistochemistry features. The second patient suffered from small-cell carcinoma of the liver. There were no risk factors for a hepatocellular carcinoma. An extensive preoperative and postoperative diagnostic investigation could rule out an extrahepatic primary site. Immunohistochemically the tumor was negative for Hepar-1, AFP, TTF1 and CDX2 but reacted positively with CD56 and sporadically with the keratins 8, 18 and 20. A neuroendocrine PHSCC was diagnosed. After neoadjuvant cytostatic treatment the carcinoma was completely extirpated and 18 months after treatment the patient is healthy.PHCT and PHSCC have to be clearly separated from hepatocellular and cholangiocellular carcinomas. Exclusion of an extrahepatic primary site requires an accurate and synoptic analysis of clinical, radiologic and pathologic findings. Surgical resection is the treatment of choice.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Tumor Carcinoide/patología , Carcinoma Neuroendocrino/patología , Carcinoma/tratamiento farmacológico , Carcinoma/patología , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/patología , Adenocarcinoma/patología , Adulto , Anciano , Carboplatino/administración & dosificación , Tumor Carcinoide/tratamiento farmacológico , Carcinoma Neuroendocrino/tratamiento farmacológico , Diferenciación Celular , Etopósido/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Neoplasias del Recto/patología , Factores de Riesgo , Resultado del Tratamiento
17.
Virchows Arch ; 448(4): 407-11, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16411132

RESUMEN

CD56 (neuronal cell adhesion molecule, N-CAM) has been reported in neuroendocrine tumours and as a marker of reactive biliary epithelial cells. However, up to date, it is not used to distinguish malignant from non-malignant biliary lesions. In this study, we systematically examined CD56 expression on 98 tumours arising from the biliary tree as well as intrahepatic conditions with reactive neoductules. When neuroendocrine carcinomas are excluded, only 4 of 32 (12.5%) cholangiocarcinomas expressed CD56, 2 of which showed clear cell morphology. Reactive bile ductules adjacent to cirrhotic nodules as well as in focal nodular hyperplasia were CD56 positive. Twelve of 17 (70.5%) bile duct adenomas were CD56 positive, whereas von Meyenburg complexes expressed CD56 only very focally in less than 5% of lesional cells. Bile duct cysts were negative for CD56 with the exception of focally interspersed neuroendocrine cells, similar to that seen in segmental bile ducts. Thus, if van Meyenburg complexes are excluded, CD56 can be used to differentiate intrahepatic non-neoplastic from neoplastic proliferations, which is a helpful diagnostic tool in small liver biopsies.


Asunto(s)
Neoplasias de los Conductos Biliares/metabolismo , Conductos Biliares Intrahepáticos/metabolismo , Biomarcadores de Tumor/metabolismo , Antígeno CD56/metabolismo , Colangiocarcinoma/metabolismo , Colangitis/metabolismo , Adenocarcinoma/diagnóstico , Adenocarcinoma/metabolismo , Adenoma de los Conductos Biliares/diagnóstico , Adenoma de los Conductos Biliares/metabolismo , Neoplasias de los Conductos Biliares/diagnóstico , Conductos Biliares Extrahepáticos/metabolismo , Conductos Biliares Extrahepáticos/patología , Conductos Biliares Intrahepáticos/patología , Colangiocarcinoma/diagnóstico , Colangitis/patología , Quiste del Colédoco/diagnóstico , Quiste del Colédoco/metabolismo , Cistoadenoma Mucinoso/diagnóstico , Cistoadenoma Mucinoso/metabolismo , Diagnóstico Diferencial , Humanos , Inmunohistoquímica , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/metabolismo
19.
Cancer Res ; 61(11): 4398-404, 2001 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-11389067

RESUMEN

Tobacco use is causally associated with head and neck squamous cell cancer (HNSCC). Here, we present the results of a case-control study that investigated the effects that the genetic variants of the cytochrome (CYP)1A1, CYP1B1, glutathione-S-transferase (GST)M1, GSTT1, and GSTP1 genes have on modifying the risk of smoking-related HNSCC. Allelisms of the CYP1A1, GSTT1, GSTM1, and GSTT1 genes alone were not associated with an increased risk. CYP1B1 codon 432 polymorphism was found to be a putative susceptibility factor in smoking-related HNSCC. The frequency of CYP1B1 polymorphism was significantly higher (P < 0.001) in the group of smoking cases when compared with smoking controls. Additionally, an odds ratio (OR) of 4.53 (2.62-7.98) was discovered when investigating smoking and nonsmoking cases for the susceptible genotype CYP1B1*2/*2, when compared with the presence of the genotype wild type. In combination with polymorphic variants of the GST genes, a synergistic-effect OR was observed. The calculated OR for the combined genotype CYP1B1*2/*2 and GSTM1*2/*2 was 12.8 (4.09-49.7). The calculated OR for the combined genotype was 13.4 (2.92-97.7) for CYP1B1*2/*2 and GSTT1*2/*2, and 24.1 (9.36-70.5) for the combination of CYP1B1*2/*2 and GSTT1-expressors. The impact of the polymorphic variants of the CYP1B1 gene on HNSCC risk is reflected by the strong association with the frequency of somatic mutations of the p53 gene. Smokers with susceptible genotype CYP1B1*2/*2 were 20 times more likely to show evidence of p53 mutations than were those with CYP1B1 wild type. Combined genotype analysis of CYP1B1 and GSTM1 or GSTT1 revealed interactive effects on the occurrence of p53 gene mutations. The results of the present study indicate that polymorphic variants of CYP1B1 relate significantly to the individual susceptibility of smokers to HNSCC.


Asunto(s)
Alelos , Hidrocarburo de Aril Hidroxilasas , Carcinoma de Células Escamosas/genética , Sistema Enzimático del Citocromo P-450/genética , Genes p53/genética , Neoplasias de Cabeza y Cuello/genética , Mutación , Carcinoma de Células Escamosas/enzimología , Estudios de Casos y Controles , Codón , Citocromo P-450 CYP1B1 , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Gutatión-S-Transferasa pi , Glutatión Transferasa/genética , Neoplasias de Cabeza y Cuello/enzimología , Humanos , Isoenzimas/genética , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Factores de Riesgo , Fumar/efectos adversos , Fumar/genética
20.
Ophthalmologe ; 113(7): 602-5, 2016 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-26362570

RESUMEN

An 82-year-old male patient presented with a salmon-pink colored conjunctival tumor of the left eye. A circumscribed, dense and whitish portion was detected by clinical examination. The histophological and immunhistochemical examination of the biopsy tissue revealed a CD20+ marginal zone lymphoma of the conjunctiva with amyloid deposits. Extranodal marginal zone lymphoma at this site is the most common lymphoma of the ocular adnexa and accounts for 5-10% of malignant diseases. An association with amyloid production is very rare and according to the current state of knowledge has no known impact on the outcome.


Asunto(s)
Amiloide/metabolismo , Conjuntiva/patología , Neoplasias de la Conjuntiva/patología , Linfoma de Células B de la Zona Marginal/patología , Anciano de 80 o más Años , Antígenos CD20/metabolismo , Proliferación Celular , Humanos , Masculino , Estadificación de Neoplasias , Linfocitos T/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA